The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
Learn more about:
Related Access Program
Related Clinical Trial
Biomarkers for Invasive Mucormycosis
Evaluation of Using 3D Printed PEEK Facial Implants in Repairing Maxillofacial Deformities
COVID-19 and Rhino-orbital Mucormycosis
Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran
COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
Patterns of Real-World Isavuconazole Use – a Study of Patients With Mucormycosis or Invasive Aspergillosis
Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis
Mucormycosis in ICU
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment